← Back to Search

Brain Computer Interface

Implantable Brain-Computer Interface for Paralysis

N/A
Waitlist Available
Research Sponsored by Synchron Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Appropriate candidate for neurointerventional procedure
Severe quadriparesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post implant
Awards & highlights

Study Summary

This trial is designed to evaluate the safety and feasibility of the MNP in humans.

Who is the study for?
This trial is for individuals with severe paralysis who can't be helped by current treatments but still have a working brain area that controls movement. They must be able to travel for tests, speak English, have someone to support them during the study, and give consent.Check my eligibility
What is being tested?
The COMMAND study is testing an implantable device called Motor Neuroprosthesis (MNP), which aims to help people with paralysis control digital devices using their thoughts by bypassing damaged nerves.See study design
What are the potential side effects?
Potential side effects are not explicitly listed in the provided information. However, as with any neurointerventional procedure or implantation of a device, there may be risks such as infection, bleeding, allergic reactions to materials or contrast media used during surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a suitable candidate for a brain or spine procedure.
Select...
I have severe weakness in all four limbs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post implant
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post implant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment-Related Serious Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: SingleExperimental Treatment1 Intervention
Implantation of the motor neuroprosthesis medical device.

Find a Location

Who is running the clinical trial?

Synchron Medical, Inc.Lead Sponsor
2 Previous Clinical Trials
15 Total Patients Enrolled
Synchron Medical, IncLead Sponsor
2 Previous Clinical Trials
5 Total Patients Enrolled
Edward KarstStudy DirectorSynchron, Inc.
5 Previous Clinical Trials
1,190 Total Patients Enrolled

Media Library

Motor Neuroprosthesis (MNP) (Brain Computer Interface) Clinical Trial Eligibility Overview. Trial Name: NCT05035823 — N/A
Quadriplegia/Tetraplegia Research Study Groups: Single
Quadriplegia/Tetraplegia Clinical Trial 2023: Motor Neuroprosthesis (MNP) Highlights & Side Effects. Trial Name: NCT05035823 — N/A
Motor Neuroprosthesis (MNP) (Brain Computer Interface) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05035823 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be an experimental subject in this medical investigation?

"This medical study requires 6 individuals aged between 21 and 75 who have suffered from a lacunar stroke. Patients need to demonstrate severe quadriparesis, give their informed consent, be suitable for the interventional procedure being tested, understand English fluently, have someone supportive of them throughout the trial, and not live too far away from available testing facilities in order to qualify."

Answered by AI

Does this experiment accept geriatric participants?

"As per the eligibilty criteria, patients applying to this medical trial must be between 21 and 75 years old."

Answered by AI

Are there vacancies remaining for individuals to participate in this investigation?

"This clinical trial is still open to participants, with the information found on clinicaltrials.gov confirming such: it was initially listed on April 27th 2022 and recently updated on August 29th 2022."

Answered by AI

How many participants are being enrolled for the trial?

"Affirmative, records found on clinicaltrials.gov indicate that the trial is actively enrolling volunteers. It was initially posted in April 27th 2022 and modified at the end of August 29th 2022. The study necessitates 6 enrollees from one centre."

Answered by AI
~1 spots leftby Aug 2024